ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 994 • 2016 ACR/ARHP Annual Meeting

    Validation Studies of the American College of Rheumatology (ACR) 2010 Fibromyalgia Diagnostic Criteria and the 2011 Self-Report Modification for Survey and Clinical Research

    Frederick Wolfe1, Daniel J. Clauw2, MaryAnn FitzCharles3, Don Goldenerberg4, Winfried Häuser5, Robert S. Katz6, Philip J. Mease7, Anthony Russell8, I Jon Russell9 and Brian Walitt10, 1National Data Bank, Wichita, KS, 2Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, 3Rheumatology, McGill University, Montreal, QC, Canada, 4Newton-Wellesley Hospital and Tufts University School of Medicine, Newton, MA., Newton, MA, 5Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, 6Rush University Medical Center, Chicago, IL, 7Swedish Medical Center and University of Washington, Seattle, WA, 8Medicine, University of Alberta, Edmonton, AB, Canada, 9Arthritis & Osteoporosis Ctr of South Texas, San Antonio, TX, 10National Institutes of Health, National Institute of Nursing Research, Bethesda, DC

    Background/Purpose: The provisional criteria of the American College of Rheumatology (ACR) 2010 and the 2011 self-report modification for survey and clinical research are widely used…
  • Abstract Number: 996 • 2016 ACR/ARHP Annual Meeting

    Use of a Shared Medical Appointment for Patients with Fibromyalgia in a Rural, Academic Medical Center: A Process Improvement Initiative for the Development of a New Care Model

    Nicole M. Orzechowski1, Debra Lloyd2, Katherine Tuthill1, Julie Puttgen3 and Rachael Bergeron1, 1Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, 2Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH

    Background/Purpose:  Fibromyalgia is a complex chronic pain condition with patients often presenting with multiple somatic complaints that are difficult to address in standard new patient…
  • Abstract Number: 997 • 2016 ACR/ARHP Annual Meeting

    2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria

    Frederick Wolfe1, Daniel J. Clauw2, MaryAnn FitzCharles3, Don Goldenerberg4, Winfried Häuser5, Robert S. Katz6, I Jon Russell7, Philip J. Mease8, Anthony Russell9 and Brian Walitt10, 1National Data Bank, Wichita, KS, 2Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, 3Rheumatology, McGill University, Montreal, QC, Canada, 4Newton-Wellesley Hospital and Tufts University School of Medicine, Newton, MA., Newton, MA, 5Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, 6Rush University Medical Center, Chicago, IL, 7Arthritis & Osteoporosis Ctr of South Texas, San Antonio, TX, 8Swedish Medical Center and University of Washington, Seattle, WA, 9Medicine, University of Alberta, Edmonton, AB, Canada, 10National Institutes of Health, National Institute of Nursing Research, Bethesda, DC

    Background/Purpose: The provisional criteria of the ACR 2010 and the 2011 self-report modification for survey and clinical research are valid, reliable and widely used for…
  • Abstract Number: 998 • 2016 ACR/ARHP Annual Meeting

    Brain Responses to Other’s Pain in Fibromyalgia – a Magnetoencephalography (MEG)  Study

    Abraham Goldstein1, Maor Wolf2 and Jacob N. Ablin3, 1Gonda Brain Research Center, Department of Psychology, Bar-Ilan University, Ramat Gan, Israel, 2Gonda Brain Research Center, Department of Psychology, Bar-Ilan University, Ramat - Gan, Israel, 3Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia Syndrome (FMS) is a disorder characterized by the presence of widespread pain and tenderness, which is now believed to be, at least in…
  • Abstract Number: 1058 • 2016 ACR/ARHP Annual Meeting

    Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients

    Fernando Estévez-López1,2, Inmaculada C Álvarez Gallardo1, Víctor Segura-Jiménez1,3, Milkana Borges-Cosic1, Manuel Pulido-Martos4, Ana Carbonell-Baeza3, Virginia A Aparicio1,5, Rinie Geenen2 and Manuel Delgado-Fernández1, 1University of Granada, Granada, Spain, 2Utrecht University, Utrecht, Netherlands, 3University of Cádiz, Cádiz, Spain, 4University of Jaén, Jaén, Spain, 5VU University Medical Care, Amsterdam, Netherlands

    Background/Purpose: Only one-third of FM patients obtain benefits after receiving one of the available therapy modalities. Insights into the heterogeneous picture of FM might improve…
  • Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting

    An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians

    Theodore Pincus and Nathaniel Cook, Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…
  • Abstract Number: 1767 • 2016 ACR/ARHP Annual Meeting

    Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?

    Stacy Weinberg1, Nisarg Gandhi2, Meenakshi Jolly3, Winston Sequeira2 and Shilpa Arora2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush, Chicago, IL

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have poorer body image (BI) than age matched controls. Few studies have been done looking at the effect…
  • Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting

    Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia

    John P. Case1, Heidi Tucker2 and Congbin Wang3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Rush Medical College, Chicago, IL, 3Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose:   The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1).  The loss of hyperextension (LOH) in a…
  • Abstract Number: 2080 • 2016 ACR/ARHP Annual Meeting

    Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care

    Amanda W. St. John1, Jonathan H. Aebischer2, Robert M. Bennett3, Madeleine J. Sanford2, Kaitlin Z. Haws4 and Kim D. Jones3, 1Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR, 2Department of Family Medicine, Oregon Health & Science University, Portland, OR, 3Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, 4Department of Internal Medicine and Geriatrics, Oregon Health & Science University, Portland, OR

    Background/Purpose:    356 patients were studied (mean age 50 ± 16.3 years, 70% female). Chart review revealed that 53 (15%) of these patients carried a…
  • Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting

    Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials

    Andrew Clair1, Ed Whalen1, Neal Thomas1 and Lynne Pauer2, 1Pfizer, New York, NY, 2Pfizer, Groton, CT

    Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…
  • Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting

    Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients

    Thomas Romano, Private Practice, Martins Ferry, OH

    Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…
  • Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting

    Association of Active Commuting and Physical Activity in Women with Fibromyalgia

    Manuel Herrador-Colmenero1, Fernando Estévez-López1, Víctor Segura-Jiménez1, Inmaculada C Álvarez-Gallardo1, Alberto Soriano-Maldonado1, Daniel Camiletti-Moirón1,2, Virginia A Aparicio1, Manuel Delgado-Fernández1 and Palma Chillón1, 1University of Granada, Granada, Spain, 2University of Cádiz, Cádiz, Spain

    Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…
  • Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting

    Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research

    Theodore Pincus1, Isabel Castrejón1, Joel Block2 and Nathaniel Cook1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
  • Abstract Number: 42 • 2016 ACR/ARHP Annual Meeting

    Small  Fibre Neuropathy Biopsies (SFN)  in  Primary Fibromyalgia Revealed  Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN)  but No Clear Distinction Related to Biopsy Results

    Euthalia Roussou1, Johnathan Chan2, Istvan Bodi3 and Aleksandar Radunivics2, 1Rheumatology, Dr, London, United Kingdom, 2Neurologist, London, United Kingdom, 3Department of Clinical Neuropathology, London, United Kingdom

    Background/Purpose: To assess patients with primary fibromyalgia (pFM) for small fibre neuropathy (SFN) and to correlate biopsy results between groups and with known causes of…
  • Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting

    Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)

    José E. Martinez1,2, Marcelo C. Rezende1,3, Eduardo Paiva1,4, Daniel Pollak1,5, Milton Helfenstein Jr1,6, Jose Roberto Provenza1,7, Aline Ranzolin1,8, Luiz Severiano Ribeiro1,9, Eduardo J. R. Souza1,10, Roberto E Heymann1,11 and Marcos Renato Assis1,12, 1Brazilian Society of Rheumatology, São Paulo, Brazil, 2Rheumatology, Pontificia Universidade Católica de São Paulo, Sorocaba, Brazil, 3Santa Casa de Campo Grande, Campo Grande, Brazil, 4Rheumatology, Universidade Federal do Parana, Curitiba Parana, Brazil, 5Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 6RUA JOAO DE LACERDA SOARES, 90, Universidade Federal de São Paulo, Sao Paulo, Brazil, 7Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, 8Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, 9Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, 10Santa Casa de Belo Horizonte, Belo Horizonte, Brazil, 11Universidade Federal de São Paulo, São Paulo, Brazil, 12Rheumatology, Faculdade de Medicina de Marilia, Marilia, Brazil

    Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 23
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology